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Abstract
Sensory experience plays a crucial role in regulating neuronal shape and in developing synaptic contacts during
brain formation. These features are required for a neuron to receive, integrate, and transmit signals within the neu-
ronal network so that animals can adapt to the constant changing environment. Insulin receptor signaling, which
has been extensively studied in peripheral organ systems such as liver, muscle and adipocyte, has recently been
shown to play important roles in the central nervous system. Here we review the current understanding of the
underlying mechanisms that regulate structural and functional aspects of circuit development, particularly with
respect to the role of insulin receptor signaling in synaptic function and the development of dendritic arbor mor-
phology. The potential link between insulin receptor signaling malfunction and neurological disorders will also be
discussed.
Introduction
The human brain is made up of billions of neurons
assembled into sophisticated circuits. Information
received from sensory neurons is processed by neurons
within distinct circuits to generate specific functional
outputs, including cognitive decisions and behavior.
A fascinating problem is how these huge numbers of
neurons establish precise connections to assemble com-
plex circuits during development. The neuron, the func-
tional unit of the brain circuit, is a highly specialized
cell composed of the cell body, the dendrite and
the axon. The structure of the dendrite determines
where and how an individual neuron can receive and
integrate information from afferent neurons, whereas
the morphology of the axon determines where processed
information is sent to efferent neurons. Sites of contacts
between the axon and dendrite, or synapses, mediate
communication between neurons for proper information
flow within the neuronal circuit. We will first review the
current understanding of cellular and molecular
mechanisms underlying synapse and dendrite develop-
ment, then focus on recent evidence suggesting a func-
tion for insulin receptor signaling in circuit function
and pathological brain diseases.
Synapse and dendrite development
Synapse development
The number of synaptic contacts and the efficacy of
synaptic transmission in the brain are dynamic through-
out development and adulthood [1-3]. These dynamics
are crucial for neurons to optimize connections in brain
circuits during development. Synaptic plasticity is also
important to optimize neuronal function in adults, for
example, to adapt to our changing environment and to
allow memories to form. Synapse development is a ser-
ies of distinct processes, including synapse formation,
synapse maturation and synapse maintenance. The
mechanisms that regulate each of these processes are
just starting to be unraveled.
Synapse formation
Synapses are specialized junctions between neurons
where the presynaptic axon terminal is packed with
synaptic vesicles and vesicle release machinery and the
postsynaptic dendritic specialization contains transmem-
brane neurotransmitter receptors, scaffold proteins and
signaling machinery (Figure 1A; see [4] for detailed
review). Time-lapse imaging in both in vivo and in vitro
preparations revealed that the temporal sequence of
synapse formation is quite rapid. The first step involves
the contact between dendrites and axons, which likely
occurs by adhesive mechanisms. Second, the presynaptic
specialization assembles quickly at sites of contact [5,6].
In fact, it is thought that components of the presynaptic
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as packets of vesicle proteins and components of the
active zone proteins [7,8], Finally, the postsynaptic spe-
cialization, including the proteins postsynaptic density-95
(PSD-95), and neurotransmitter receptors, including
N-methyl-D-aspartate (NMDA) receptors, are thought
to arrive somewhat later during synapse formation
(Figure 1B) [9]. Although the assembly of synapses is a
complex process, recent work has identified several mole-
cules that are important in different steps of synapse for-
mation [7,10]. For example, molecules that are present in
gradients within target regions, such as ephrins, play an
important role in directing axons and dendrites to the
correct brain regions [11,12]. Adhesion molecules, such
as cadherin, are thought to be important in establishing
of the initial axodendritic contacts [13,14]. Some
Figure 1 Schematic diagram of an excitatory synapse and the temporal sequence of synapse formation and maturation. (A) Synapses
are specialized junctions between neurons composed of complex membrane and proteins. A synapse can be divided structurally into three
parts: a presynaptic axon terminal packed with synaptic vesicles (SV) and release machinery, a synaptic cleft, and a postsynaptic dendritic
counterpart filled with neurotransmitter receptors, scaffold proteins and signaling machinery. (B) Synapse formation is initiated by the contact
between dendrites and axons, followed by the recruitment of presynaptic and postsynaptic specializations. Increases in synapse size and synaptic
strength by accumulation of AMPA receptors at synapses are characteristics of synapse maturation. AMPAR, a-amino-3-hydroxy-5-methyl-4-
isoxazole propionic acid receptor; CaMKII, Calcium calmodulin dependent kinase type II; CASK, calcium calmodulin-dependent serine kinase;
GKAP, guanylate kinase-associated protein; GRIP, glutamate receptor-interacting protein; InsP3R, inositol triphosphate receptor; mGluR,
metabotropic glutamate receptor; NMDAR, N-methyl-D-aspartate receptor; PSD, postsynaptic density; PSD-95, postsynaptic density protein-95;
RIM, Rab3-interacting molecule; SAP, synapse-associated protein; SER, smooth endoplasmic reticulum; SPAR, spine-associated Rap GTPase
activating protein; VAMP, vesicle-associated membrane protein; VGCC, voltage-gated calcium channel. (Adapted and modified from [4]).
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are crucial in bidirectional signaling and the recruitment
of both pre- and postsynaptic proteins to new synapses
[15,16]. In addition to molecular players, neuronal activ-
ity appears to be another key regulator in the formation
of nascent synapses [17-20].
Synapse maturation
Synapse maturation is characterized by an increase in
the morphological size and transmission strength of the
synapse, which includes changes in both the presynaptic
axon terminal and the postsynaptic dendrite. From the
presynaptic point of view, a prominent ultrastructural
feature of synaptic maturation is the increase in the
number of synaptic vesicles per terminal [21-23], which
likely contributes to the increase in probability of trans-
mitter release in mature synapses [17]. Transmission at
immature glutamatergic synapses is mainly mediated by
NMDA receptors, which shift their kinetics by replacing
NMDA receptor subunit 2B-containing receptors with
NMDA receptor subunit 2A-containing receptors
[24,25]. These immature synapses can be silent or have
low synaptic strength at resting membrane potentials
because of voltage-dependent magnesium blockade of
the NMDA receptor. As the synapses mature, a-amino-
3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)
receptors are recruited to the postsynaptic membrane,
and in addition to NMDA receptors, provide fully func-
tional glutamatergic synaptic transmission [26-29]. Neu-
ronal activity reportedly induces synapse maturation by
promoting the incorporation of NMDA receptor subunit
2A-containing NMDA receptors into synaptic sites.
Furthermore, activity recruits AMPA receptors to the
postsynaptic site to activate silent synapses and increase
the strength of synaptic transmission (Figure 1B)
[4,26,27].
Synapse maintenance or synapse elimination
The precise connectivity required for circuit function
relies not only on the formation of new contacts but
also the maintenance of the correct synapses. In fact,
the density of synapses formed at early stages of devel-
opment is far greater than the density retained at later
stages, indicating that only selective synapses are stabi-
lized and maintained during development [30]. The
importance of synapse maintenance is well documented
at the neuromuscular junction, where each muscle fiber
is temporarily innervated by multiple motor axons but
only one input becomes stabilized while others are
eliminated [31,32]. A reduction in synapse density has
also been demonstrated in various regions of the central
nervous system (CNS) [33-37], suggesting synapse elimi-
nation could be a common process for refining the
brain circuits during development. For instance, climb-
ing fiber to Purkinje cell synapses in cerebellum undergo
synapse elimination at early postnatal ages in mammals.
Although the detailed mechanisms regulating synapse
elimination and maintenance remain largely unknown,
neuronal activity appears to contribute to the mainte-
nance of correct synapses while weaker synapses are
usually eliminated [34,38,39]. Additionally, molecular
players such as insulin-like growth factor (IGF)-2, com-
plement protein 1q, major histocompatibility complex
protein, protein kinase Cg, metabotropic glutamate
receptor subtype 1, and glutamate receptor (GluR) delta
2 subunit reportedly regulate synapse maintenance or
elimination [40-45].
Dendrite development
The architecture of the dendritic arbor contributes to
the precise patterning of synaptic connections required
for normal circuit function. Dendritic structure not only
determines which axons are potential presynaptic part-
ners, but also determines how the inputs are integrated.
T h em a r r i a g eo fs i n g l ec e l ll a b e l i n ga n din vivo time-
lapse imaging has made it possible to explore the cellu-
lar mechanisms underlying dendritic development
[19,20,46,47]. Advances in microscopy, cell biology and
molecular genetic methods have paved the way for sig-
nificant advances in our understanding of the mechan-
isms behind the molecular and activity-dependent
regulation of dendrite development.
Cellular mechanisms
Imaging optic tectal neurons in vivo in Xenopus tadpoles
showed that dendritic arbor elaboration goes through
distinct phases (Figure 2A) [19,48]. Many newly differ-
entiated neurons first undergo axonogenesis with only
little elaboration of the dendritic arbor. About one day
after evidence of morphological differentiation, neurons
go into a rapid dendritic arbor growth phase for a few
days until they enter the third phase, characterized by a
slower dendritic arbor growth rate and more stable den-
dritic arbors. During the rapid dendritic arbor growth
period, one might think that the growth of the dendritic
arbor can be easily achieved by continuously lengthen-
ing pre-existing dendrites and sprouting new dendritic
branches; however, time-lapse imaging at intervals of
minutes to hours reveals that dendritic growth is highly
dynamic, consisting of not only branch addition and
extension, but also retraction and loss of dendritic
branches (Figure 2B) [18,49-52]. It is worth noting that
these dynamics in dendritic morphogenesis persist in
mature neurons when their overall structure is stable,
although at a slower rate [20,53-55]. Therefore, it is very
likely that mechanisms that regulate dendritic dynamics
early during development may also play a role in dendri-
tic plasticity later in life.
Molecular mechanisms
Mechanisms that regulate cytoskeleton architecture play
a crucial role in shaping dendritic arbors because the
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dendritic structure. Filopodia are thin, highly motile
actin-based protrusions and some of them are trans-
formed into more stable microtubule-based dendritic
branches. The Rho family of small GTPases, including
Rac, RhoA, and Cdc42, regulate the rearrangement of
cytoskeleton and participate in distinct aspects of den-
drite morphogenesis [56,57]. For example, Rac and
Cdc42 activity promote dendritic arbor dynamics by
increasing the rate of actin polymerization, whereas
increased RhoA activity inhibits dendritic arbor growth
in Xenopus tectal neurons [57]. Consistently, several
guanine exchange factors that activate Rac, such as
Tiam1 [58] and STEF [14,59,60], have been shown to
regulate neurite formation whereas Rho-specific guanine
exchange factors, such as KIAA0380 [14], and Rho-spe-
cific GTPase activating proteins, such as p190 RhoGAP
[61], which activate or inactivate Rho, respectively, have
been shown to regulate neurite retraction [14,59,60]in
vitro. Interestingly, there is considerable crosstalk
among these Rho GTPases. RhoA activity was increased
by Rac activation and Cdc42 inhibition, whereas Rac
was inhibited by activation of Rho in Xenopus tectal
neurons in vivo [62]. This tight cross-regulation of Rho
GTPases seems to work together to determine the struc-
ture of the dendritic tree. What controls the activity of
Rho GTPases is a key question to understand the under-
lying mechanisms in dendritic morphogenesis.
In the Xenopus visual system visual activity promotes
dendritic arbor growth through mechanisms that require
both glutamate receptor activity and Rho GTPase activ-
ity in Xenopus tectal neurons [63]. Accordingly, the
working hypothesis is that glutamate receptor activity
promotes dendritic growth by elevating Rac and Cdc42
activities, leading to increased branch dynamics, and
concurrently decreasing RhoA activity to relieve its inhi-
bition on branch extension [63]. In addition to Rho
GTPases, several other molecular mechanisms, including
Figure 2 Dendritic arbor growth and dynamics. (A) Dendrite development can be divided into three phases: phase I, the cell differentiates
and extends an axon with little elaboration of the dendritic arbor; phase II, the dendritic arbor grows rapidly; phase III, the dendritic arbor grows
slowly and appears stable. Reconstruction of the same tectal neuron imaged in vivo daily for 5 days is shown on top. (Adapted and modified
from [19,48].) (B) Dendritic growth is highly dynamic as revealed by time-lapse imaging at 2-hour intervals over a 6-hour imaging period. Stable
branches, retracted branches, transient branches, and added branches are shown in gray, red, green and yellow, respectively. Cell bodies are
shown in purple. (Adapted from [52].)
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and calcium calmodulin dependent kinase type II [67],
or local protein synthesis, mediated by cytoplasmic poly-
adenylation [47], have been shown to regulate dendritic
arbor development in an activity-dependent manner.
These data suggest that dendritic arbor growth is orga-
nized by signals from their surrounding environment.
Synaptic function and dendritic development
During circuit development, the increase in synapse
number and synaptic strength occur concurrently with
the elaboration of dendritic arbors, suggesting a coordi-
nated regulation of synaptic function and dendritic devel-
o p m e n t .A l m o s tt w od e c a d e sa g o ,V a u g h nf i r s tp r o p o s e d
the ‘synaptotrophic hypothesis’, which states that the sta-
bilization of synapses might stabilize the dendritic
branches and thereby explain the coordinated develop-
ment of synapses and dendritic arbors [68]. Recent
research has provided new supporting evidence for this
hypothesis. Adhesion molecules, which play important
roles in the initial assembly and stabilization of the
synapses, regulate dendritic arbor development in mam-
mals and flies [69,70]. Moreover, live imaging of synapse
formation and dendrite growth in zebrafish showed that
the presence of the synapses associated with the stabiliza-
tion of terminal dendrites [71]. On the other hand, block-
ade of synaptic transmission or synapse maturation
reduces dendritic arbor elaboration and blocks activity-
dependent dendritic growth in Xenopus [18,50,52,63,72].
It is interesting to note that decreasing GABAergic trans-
mission also changes the pattern of dendritic arbor
growth and blocks visual experience-dependent struc-
tural plasticity [73]. These data suggest that synaptic con-
tacts and synaptic transmission regulate the growth and
elaboration of complex dendritic arbors in sculpting
circuit function during development.
The insulin receptor
The insulin receptor is a receptor tyrosine kinase well
studied with regard to its function in the regulation of
peripheral glucose metabolism. Although expression of
the insulin receptor in the brain was discovered decades
ago [74,75], insulin receptor function in this classic
‘insulin-insensitive’ organ remains largely unknown.
Recent studies in neuronal cell culture suggest that insu-
lin receptor signaling regulates several neuronal func-
tions, including spine density and neurite growth
[76,77]; however, the role of insulin receptor signaling
in controlling structure and function of CNS circuit
development has not yet been widely explored in vivo.
Structure and signaling of the insulin receptor in
peripheral tissues
The insulin receptor was first found as a homodimer,
with extrinsic disulfide bonds to generate the functional
receptor. Each monomer of the insulin receptor is com-
posed of one a and one b subunit bridged by an intrin-
sic disulfide bond [78,79]. The 135-kDa a subunit is the
extracellular ligand binding portion, whereas the 95-kDa
b subunit consists of an extracellular, a single trans-
membrane, and an intracellular kinase domain. Ligand
binding to the a subunits activates the intrinsic kinase
activity located in the b subunits and subsequently initi-
ates a cascade of phosphorylation events that leads to
different biological functions (Figure 3A) [80].
Crystal structures of the unphosphorylated and phos-
phorylated kinase domains of the insulin receptor have
provided detailed information on how insulin receptor
kinase activity is initiated. The kinase domain is com-
posed of two lobes, the amino- and carboxy-terminal
lobes, with an activation loop in between. In the unpho-
sphorylated state, the activation loop traverses the cleft
between two lobes such that both ATP binding and pro-
tein substrate-binding sites are blocked. More specifi-
cally, while residues in the beginning of the activation
loop restrict the access of ATP to its binding sites on
the insulin receptor, tyrosine 1162, one of the three
phosphorylation sites in the activation loop, binds to
the active site and competes with the kinase substrates
[81]. Autophosphorylation of tyrosine 1158, 1162 and
1163 in the activation loop of the kinase domain causes
rearrangement of the activation loop and reorientation
of the amino- and carboxy-terminal lobes of the kinase,
which is necessary for productive ATP binding. Tyrosine
1163 is the key phosphotyrosine in stabilizing the con-
formation of this phosphorylated activation loop,
whereas tyrosine 1158 is accessible for interaction with
downstream signaling proteins [81]. The knowledge of
insulin receptor structure not only provides valuable
understanding on how insulin receptor signaling is
transduced but also allows functional analysis following
the generation of various mutants of the putative ATP
binding site or phosphorylation sites [82-85].
Unlike other receptor tyrosine kinases, most functions
of the insulin receptor require accessory molecules
known as insulin receptor substrates (IRSs) - for example
IRS1-4- to engage multiple downstream signaling [86,87].
Two major cellular signaling pathways, phosphoinositide-
3 kinase (PI3K)/Akt and the Ras/mitogen-activated pro-
tein kinase (MAPK) pathways, can be activated by the
kinase activity of insulin receptor. These cascades regu-
late diverse cellular processes, such as gene expression,
protein synthesis, and vesicle trafficking, which result in
the regulation of glucose, lipid and protein metabolism,
cell growth and differentiation (Figure 3C) [88,89].
Diversity of the insulin receptor
Although the insulin receptor is encoded by one single
gene, various processes give rise to considerable
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alternative splicing produces two isoforms of insulin
receptor, IRa, an exon-11 lacking form, and IRb, an
exon-11 containing form in a tissue-specific manner.
Moreover, post-translational glycosylation contributes to
different modifications of these receptors in different
cell types or tissues [90]. Furthermore, assembly of
hybrids between different isoforms and heterodimers
with homologous IGF-1 receptor results in further
diversity [91,92]. Although different ligand binding affi-
nity and selectivity have been reported for insulin recep-
tors, the physiological significance of the splice variance,
post-translational modification and homo- or hetero-
dimerization between different insulin receptors and
IGF-1 receptor remain largely unknown (Figure 3B)
[86,93]. Neurons have mainly the IRa isoform with less
glycosylation compared to glial cells or peripheral tissues
[94]. The different properties of neuronal insulin
receptors might suggest different roles of insulin recep-
tors in the CNS. Interestingly, IRa binds insulin or
IGF-2 with comparable affinity [95] and hybrids of IRa
with the IGF-1 receptor binds IGF-1, IGF-2 and insulin
with similar affinity [86,93]. Taken together, these data
suggest that, in addition to insulin, IGF-1 and IGF-2 are
potential ligands for the insulin receptor in the brain.
The capability of neuronal insulin receptors to interact
with various ligands suggests that insulin receptors may
play versatile functions in the CNS.
In contrast to other species, Xenopus laevis has two
insulin receptor genes, which we isolated from brain
cDNA libraries. At the nucleotide level, these two Xeno-
pus brain insulin receptors are highly similar to each
other (93.6% identity) and are splice variants homolo-
gous to a human brain isoform of insulin receptor
lacking exon-11 [96]. At the amino acid level, the corre-
sponding peptides of these two Xenopus insulin
Figure 3 Insulin receptor structure and signaling. (A) Insulin receptor monomer, composed of an a (yellow) and b subunit (pink) bridged by
an intrinsic disulfide bond, which dimerizes with another insulin receptor monomer through extrinsic disulfide bonds to form a functional
receptor. (Adapted and modified from [80].) (B) Ligand selectivity of the insulin receptor homodimer or heterodimer with the insulin-like growth
factor (IGF)-1 receptor. Note that the homodimer of the splice variant IRa, the predominant form of inslulin receptor in the brain, binds
specifically to insulin (INS), whereas the heterodimer with the IGF-1 receptor binds to not only INS but also IGF-1 and IGF-2. (Adapted and
modified from [86].) (C) Insulin receptor signaling initiated by ligand binding activates tyrosine autophosphorylation in the b subunit, which
stimulates two major downstream pathways, the phosphoinositide-3 kinase (PI3K)/Akt and Ras/mitogen-activated protein kinase (MAPK)
cascades, through insulin receptor substrates (IRSs) and results in a diverse series of cellular processes in peripheral tissues. (Modified from [88].)
GSK3, glycogen synthase kinase 3.
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tity and 97% similarity. Since only one insulin receptor
gene has been reported in human or other vertebrates,
the two copies of insulin receptor genes potentially
result from the tetraploid nature of the X. laevis genome
[97]. Alignment of the amino acid sequence of IR1,t h e
more abundant Xenopus insulin receptor, with other
species showed that the Xenopus insulin receptor shares
overall identities of 70%, 69% and 69% with those of
human, rat and mouse, respectively (Figure 4). Detailed
alignments of different domains of insulin receptor
further revealed that the kinase domain of the Xenopus
insulin receptor shares the highest identity of 87 to 88%
with that of human, rat and mouse compared to other
regions (Figure 4). In addition, the potential ATP bind-
ing site and phosphorylation sites on the activation loop
of the kinase domain [81] are remarkably identical to
those of human, rat and mouse, suggesting that these
amino acids may play a functional role in insulin recep-
tor action and thus are well conserved in evolution.
This also suggests that it is suitable to be mutated for
studying insulin receptor function in vivo.
Expression pattern of insulin receptor in the brain
The insulin receptor is distributed in a widespread, but
selective, pattern in the brain, including olfactory bulb,
cerebral cortex, hypothalamus, hippocampus and cere-
bellum as reported in rodents [74,75,90]. The expression
level of the insulin receptor is developmentally regu-
lated, being higher at early stages and lower in the
adult. At the cellular level, the insulin receptor is
enriched in neurons compared to glia [74]. Subcellularly,
the insulin receptor is a component of synapses, where
it concentrates at the postsynaptic density (PSD) in cul-
tured hippocampal neurons [98]. These data together
suggest that the insulin receptor is in the right place at
the right time to regulate the initial neuronal develop-
ment by regulating synaptic function in the CNS.
Although the IGF-1 receptor, which can dimerize with
the insulin receptor and affect its ligand affinity and spe-
cificity, as mentioned previously, shows a similar distri-
bution in the brain as the insulin receptor, it also
exhibits a distinct expression pattern compared to the
insulin receptor when examined in detail locally [99].
For example, both receptors are highly expressed in hip-
pocampus; however, insulin receptor mRNA is more
abundant in the CA1 region whereas IGF-1 receptor
mRNA is greater in the CA3 region, implying that insu-
lin/IGF-1 receptor signaling may play distinct roles in
subregions of the hippocampus.
Function of insulin receptor in circuit development and
plasticity
Brain insulin receptor signaling reportedly plays diverse
roles in the CNS, including regulation of synaptic plasti-
city [100-106], dendritic outgrowth [77,107], and involve-
ment in neuronal survival [108,109], life span [110-114],
learning and memory [115-117], and neurological disor-
ders [118-121]. A role for insulin receptor signaling in
synaptic function and dendritic morphogenesis, there-
fore, makes it a potential regulator of circuit development
and circuit function.
Synaptic function
Recent work suggests insulin receptor signaling is
involved in postsynaptic neurotransmitter receptor traf-
ficking. For excitatory receptors, insulin accelerates cla-
thrin-dependent endocytosis of GluR2 subunit-containing
AMPA receptors and contributes to long-term depression
[100,102,122-124]. In contrast, insulin reportedly acceler-
ates GluR1 subunit-containing AMPA receptor insertion
into the membrane in a GluR1 subunit-dependent man-
ner in cultured hippocampal neurons [104]. Therefore,
the physiological significance of insulin receptor signaling
in AMPA receptor-mediated transmission is somewhat
controversial and needs to be further studied in vivo.
Moreover, insulin promotes the delivery of NMDA
Figure 4 Protein sequence alignment of X. laevis insulin receptor IR1 with different species. Amino acid sequence derived from Xenopus
IR1 was aligned with rat, mouse and human insulin receptor protein sequences with the ClustalW algorithm. Schematic drawing of the
alignment identities (percentages) in different functional domains of insulin receptor. Note that the predicated Xenopus kinase domain shares the
highest identity with other species compared to other domains.
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oocytes expressing recombinant NMDA receptor [105].
For inhibitory receptors, insulin rapidly recruits type A
g-aminobutyric acid (GABAA) receptors to the postsynap-
tic membrane in cultured hippocampal neurons [106].
These data suggest that insulin receptor signaling is cap-
able of regulating both excitatory and inhibitory synaptic
transmission in the CNS. In addition, brief incubation of
insulin results in increased protein synthesis of PSD-95, a
dendritic scaffolding protein that associates neurotrans-
mitter receptors and cytoskeletal elements at synapses in
hippocampal slices and synaptosomes [125], also suggest-
ing that insulin receptor signaling can potentially regulate
structural aspects of synaptic function, synaptogenesis
and synapse maturation.
Recently, our laboratory provided direct in vivo
evidence for the function of insulin receptor signaling
in both the structure and function of brain circuit devel-
opment in the visual system of live Xenopus tadpoles
[84]. The retinotectal circuit of Xenopus (see schematic
in Figure 5), in which tectal neurons receive direct
visual input from the retinal ganglion cells in the eye
[126], is a powerful experimental system to study
both structural [47,52,63,73] and functional plasticity
[17,36,47,73,127-130]in vivo. By taking advantage of the
Xenopus visual circuit as an in vivo experimental system
amenable to molecular manipulation, electrophysiology
and a variety of imaging methods, we showed that the
insulin receptor is required for optic tectal neurons to
receive normal levels of visual input within the retino-
tectal circuit [84]. Reduced insulin receptor phosphory-
lation by ectopic expression of dominant negative
insulin receptor (dnIR), which contains a point mutation
to abolish insulin receptor binding to ATP, or decrease
insulin receptor protein by morpholino-mediated knock-
down in tectal neurons, severely decreases their gluta-
matergic synaptic input and reduces their responses to
natural light stimuli (Figure 5). Few studies have made a
direct comparison between the effects of protein knock-
down and dominant negative interference with signaling.
It is interesting to note that decreasing insulin receptor
signaling either by expression of a dominant negative
receptor or by morpholino-mediated knockdown leads
to a comparable magnitude of functional impairment in
visual system processing, suggesting that the presence of
the protein itself does not play a role in visual system
development independent of its kinase-dependent
signaling.
Dendritic morphogenesis
Several molecules downstream of the insulin receptor,
including both the Ras/MAPK and PI3K/Akt/mamma-
lian target of rapamycin (mTOR) pathways, have been
implicated in excitatory synaptic connectivity as well as
dendritic structure [131,132]. IRSp53, a novel insulin
receptor substrate enriched in the brain, where it loca-
lizes to synapses as a component of the PSD [98], is par-
ticularly interesting. Structural analysis predicted that
IRSp53 contains several protein-protein interaction
domains, including an amino-terminal F-actin bundling
domain [133,134], a central Cdc42/Rac interactive bind-
ing (CRIB) motif [135], a Src homology region 3 (SH3)
domain [76,136,137], a proline rich SH3-binding domain
[136], a proline-rich WW-binding motif [136], and a
carboxy-terminal postsynaptic density-95/discs large/
zona occudens-1 (PDZ) domain [76,138]. Biochemical
studies showed that it directly interacts with PSD scaf-
fold proteins, Shank and PSD-95 [76,137-139], small
GTPases such as Rac and Cdc42 [77,139-141], and actin
regulators such as WAVE2 and Mena [140,141]. These
data together suggest a link between insulin receptor
signaling and the structural stabilization of excitatory
synaptic contacts through the association of synaptic
scaffolding proteins and the cytoskeleton. In fact, these
ideas were further supported by the findings that over-
expression of IRSp53 can increase spine density in cul-
tured hippocampal neurons [76] and induce filopodium
formation and neurite outgrowth in N1E-115 neuroblas-
toma cells [77,142], whereas RNA interference knock-
down of IRSp53 protein decreases spine density and
alters spine morphogenesis [76]. Another line of evi-
dence supporting the idea that insulin receptor plays a
role in dendritic arbor development comes from trans-
g e n i cm i c el a c k i n gI G F - 1 ,ap o t e n t i a ll i g a n df o ri n s u l i n
receptor and IGF-1 receptor heterodimer receptors in
the brain. Pyramidal neurons from the IGF-1 null mice
showed significant reduction in dendritic arbor length
and complexity as well as spine density [107].
Experience-dependent dendritic plasticity
Activity shapes synaptic connectivity and dendritic mor-
phogenesis in the CNS, particularly in sensory regions.
Interestingly, insulin is released from neurons upon
depolarization [143,144] andI R S p 5 3t r a n s l o c a t e st o
synapses in response to activity [145], suggesting that
insulin receptor signaling may increase in an activity-
dependent manner. Consistent with this idea, we have
shown recently that insulin receptor signaling plays an
important role in visual experience-dependent structural
plasticity [84]. More specifically, enhanced visual stimu-
lation normally induces tectal neurons to increase their
rate of dendritic growth by increasing branch length
extension and branch tip stabilization. In the absence of
insulin receptor signaling, however, more branches
shorten and more branches are lost during the period of
visual stimulation.
Insulin receptor signaling and synaptic structure
As mentioned earlier, reduced insulin receptor protein
and signaling in Xenopus visual system showed that
insulin receptor signaling is required for optic tectal
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and undergo activity-dependent dendritic arbor growth.
To probe the role of insulin receptor signaling in devel-
opmental plasticity of the glutamatergic synapse, we
examined the spontaneous AMPA receptor-mediated
miniature excitatory postsynaptic currents (mEPSC) in
dnIR-expressing neurons. We found that they have
much lower mEPSC frequency but equivalent amplitude
compared to controls, indicating that either presynaptic
vesicle release probability or synapse number is reduced
in dnIR-expressing neurons. Because the paired-pulsed
ratio with retinal ganglion cell axon stimulation in
dnIR-expressing neurons did not change, it is unlikely
that the lower mEPSC frequency in dnIR-expressing
neurons is due to low probability of release. To test
whether synaptic contacts onto dnIR-expressing tectal
neurons were changed in dnIR-expressing neurons, we
used electron microscopy to estimate synapse density on
tectal neurons. This methodology gives both definite
identification of synaptic contacts onto transfected neu-
rons and ultrastructural information about both pre-
and post-synaptic profiles [23]. We estimated synapse
density by measuring the number of green fluorescent
protein (GFP)-labeled synapses normalized to the total
area of GFP-labeled dendritic profiles and found that
dnIR-expressing dendrites had less than half of the
synapse density of GFP-labeled neuron controls,
although no changes in other ultrastructural features or
synapse maturation were observed (Figures 6A-C) [84].
These observations, according to both electrophysiologi-
cal and ultrastructural data, together with decreased
dendritic plasticity in dnIR-expressing neurons, suggest
that insulin receptor signaling maintains both synaptic
contacts and the branches they sit on, which in turn
Figure 5 Recording of visual responses in an intact animal. (A) X. laevis tadpole. (B) Diagram of the Xenopus visual circuit. Optic tectal
neurons receive direct visual input from retinal ganglion cells of the eye. (C) Experimental setup. Visual stimulation was delivered with a green
LED pigtailed to an optic fiber that illuminates the entire eye for whole field stimulation. The tadpole brain was cut along the midline to expose
the cell bodies. Visual responses from tectal neurons contralateral to the stimulated eye were recorded by whole-cell recording. (D) Visual
responses of tectal neurons. Tectal neurons respond to transient light intensity change. The OFF responses induced by light off is normally
bigger in amplitude and longer in duration than ON responses induced by light on. Superimposition of 20 consecutive responses (gray) and the
averaged trace (black) are shown. Adapted from [84]. dnIR, dominant negative insulin receptor; moIR, morpholino-mediated knockdown of
insulin receptor; wtIR, wild-type insulin receptor.
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Page 9 of 18Figure 6 Insulin receptor signaling regulates synapse numbers. (A) Electron micrographs show ultrastructural morphology of synaptic
terminals that contact green fluorescent protein (GFP)-, wild-type insulin receptor (wtIR)- and dominant negative insulin receptor (dnIR)-
expressing dendrites. The postsynaptic area, presynaptic area and the clustered synaptic vesicle are highlighted in light blue, green, and pink,
respectively. (B) dnIR-expressing dendrites receive significantly fewer synaptic contacts compared to GFP- and wtIR-transfected dendrites. (C)
Synapses that contact GFP-, wtIR- and dnIR-expressing dendrites show comparable ultrastructural synaptic maturity, determined by the area
occupied by clustered synaptic vesicles relative to the area of the presynaptic terminal. (D) Schematic cartoon showing that normal tectal
neurons increase total synapse number and, therefore, synaptic transmission, branch stabilization and extension in response to enhanced visual
stimulation, whereas tectal neurons expressing dnIR do not increase synapse number and fail to increase synaptic function and dendritic
structural plasticity.
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experience.
Our observations are consistent with the synapto-
trophic hypothesis, which states that the formation and
maintenance of synapses promote the stabilization of
dendritic branches and that dendritic arbor growth cor-
relates positively with the number and strength of
synapses [18]. In the optic tectum of Xenopus,v i s u a l
experience increases dendritic arbor growth rate, retino-
tectal synaptogenesis and retinotectal synaptic strength
[17,52,63,128,146]. Similarly, in zebrafish, synapses
appear to stabilize growing dendrites and promote
further dendrite branch growth in tectal neurons [71].
Conversely, blocking synapse maturation by interfering
with AMPA receptor trafficking into synapses reduces
dendritic arbor elaboration and completely blocks the
visual stimulation-induced increase in dendritic arbor
growth [52]. Therefore, the visual stimulation-induced
increase in synapse number and strength [17] appears to
stabilize newly extended dendritic branches. The failure
of neurons with decreased insulin receptor signaling to
increase their growth rate in response to visual stimula-
tion could be a result of their low synapse density. One
potential mechanism by which a lower synapse density
could affect experience-dependent structural plasticity is
that these neurons do not form and maintain synapses
on newly added branches, and they are consequently
retracted. The alternative, but not mutually exclusive,
mechanism is based on the fact that, in these experi-
ments, we transfected single tectal neurons within an
otherwise normal optic tectum. Therefore, while sur-
rounding tectal cells, which have twice the synapse den-
sity of the dnIR-expressing neurons, respond to visual
stimulation normally and can increase their synapses
and promote dendritic growth, the single dnIR-expres-
sing neuron, which responds to visual inputs very
weakly, may not be able to compete with normal neigh-
boring tectal neurons for retinal inputs. Consequently,
this might lead to branch length retraction and branch
loss in the insulin receptor signaling deficient neurons.
Unexpectedly, we found that dnIR-expressing neurons
can still elaborate their dendrites over a period of sev-
eral days even when synapse density is low during early
development. A similar observation was reported with
manipulation of levels of the neurotrophin brain-derived
neurotrophic factor, which significantly changed synapse
number but not dendritic arbor morphology [147]. In
the case of insulin receptor signaling where experience-
dependent structural plasticity is decreased when
assayed over a period of 4 hours, these daily imaging
data suggest that under conditions of decreased synaptic
input, alternative mechanisms participate in dendritic
arbor growth control.
Insulin receptor signaling and neurological diseases
Emergent evidence suggests an association of insulin
receptor signaling with several neurological disorders.
Although the role that the insulin receptor may play in
these disorders is still a puzzle, enhanced brain insulin
receptor signaling has been used to treat schizophrenia
patients early in the mid-20th century [148,149] and
insulin sensitizing drugs are now in clinical trials for the
treatment of Alzheimer’s disease [150-152], highlighting
its importance in both neuronal developmental and
degenerative diseases.
Neurodegenerative diseases
Reduced mRNA and protein levels have been reported
in postmortem material from patients with neurodegen-
erative disorders, for example Alzheimer’s sisease
[118,153] and Parkinson’s disease [119], implying a role
for insulin receptor signaling in neurodegenerative dis-
eases. Among these, Alzheimer’s disease is the best-stu-
died neurodegenerative disease with respect to insulin
receptor signaling.
Alzheimer’s disease, the most common brain degen-
eration characterized clinically by progressive decline of
memory and pathologically by loss of synapses, forma-
tion of neurofibrillary tangles and neuritic plaques, has
been extensively studied with respect to insulin receptor
signaling. Insulin receptor signaling inhibits a key event
in the formation of neurofibrillary tangles by reducing
tau protein phosphorylation [154,155]. Additionally,
insulin receptor signaling prevents plaque formation by
modulating amyloid b (Ab)r e l e a s e[ 1 5 6 ]a n dd e g r a d a -
tion [157-160].
Although tangle formation and amyloid deposits are
useful diagnostic markers, synapse loss is more robustly
correlated with cognitive deficits than any other patho-
logical lesion observable in Alzheimer’sp a t i e n t s
[161-164]. Progressive accumulation and toxicity of Ab
oligomers is the leading hypothesis for etiology of Alz-
heimer’s disease [163]. Interestingly, the Ab oligomer
induces glutamatergic synapse loss [165,166], which in
addition to cholinergic synapses seems to be most
severely affected in Alzheimer’s disease patients
[167,168].
Furthermore, increasing evidence shows that Ab binds
to the insulin receptor, decreases the relative amount of
insulin receptor in the dendritic compartment, and
causes neuronal oxidative stress and loss of spines
[153,169-171]. Intracellularly, Ab is reported to block
insulin receptor signaling by reducing Akt activation
and eliminating its neuroprotective benefit [172,173].
Our data suggesting that insulin receptor signaling is
required to maintain synapses are consistent with the
model that Ab leads to loss of synapses by directly
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insulin receptor signaling. Our data further support the
idea that synapse loss resulting from reduced insulin
receptor signaling will decrease experience-dependent
structural plasticity and ultimately lead to deficits in cir-
cuit function, including information processing and inte-
gration. By contrast, reduced IGF-1 receptor function
also reportedly decreases Ab toxicity and ameliorates
neuronal/synaptic loss in animal models of Alzheimer’s
disease [174,175]. The seemingly opposite outcomes
from decreased insulin receptor and IGF-1 receptor sig-
naling implies that either they initiate different pathways
or they share the same signaling pathway but bi-direc-
tionally regulate Ab toxicity and synaptic loss in Alzhei-
mer’s disease.
Neuronal developmental disorders
Several neuronal developmental disorders are thought to
be associated with insulin receptor signaling malfunc-
tion. For instance, schizophrenia is a chronic neurodeve-
lopmental disorder that affects approximately 1.1% of
the US population, and decreased insulin receptor pro-
tein and activity and altered downstream signaling have
been reported in post-mortem schizophrenia patients
[121]. Although the underlying mechanism is poorly
understood, insulin treatment of schizophrenic patients
was initiated during the 1930s and reportedly gives
effective clinical results, [148,149]. Surprisingly, schizo-
phrenia and Alzheimer’s disease share some early patho-
logical hallmarks, such as impaired synaptic connectivity
[176-178] and abnormal dendritic structure [179,180],
that eventually result in impaired circuit function and
aberrant cognitive behavior.
Another example is tuberous sclerosis (TSC), a genetic
disorder resulting from mutation in one of the two
tumor suppressor genes, TSC1 or TSC2,t h a to f t e ng i v e
rise to multiple neurological deficits such as epilepsy,
mental retardation and autism. Interestingly, loss of
TSC function decreases synaptic transmission and alters
spine morphology through the mTOR pathway, which
overlaps with insulin receptor signaling [181]. One
potential etiology for TSC-related neuronal deficits
could be their ability to negatively regulate insulin
receptor signaling in the brain as reported in the fly and
in mammalian cell lines [182,183].
It is now recognized that molecules that regulate aging
can also affect early neuronal development. For example,
cyclin-dependent kinase 5, which plays roles in neuronal
migration in the developing CNS, is also involved in the
pathology of Alzheimer’s disease [184]. Insulin receptor
signaling, therefore, might participate at both ends of
the story: early development as well as later neurodegen-
erative diseases.
Perspectives
Accumulating data support the idea that insulin recep-
tor signaling plays a prominent role in both structural
and functional aspects of circuit development. The
detailed cellular and molecular mechanisms by which
insulin receptor signaling control synaptic function and
dendritic structure are still to be determined. Besides
the role of insulin receptor signaling in circuit forma-
tion, insulin receptor signaling has been linked to sev-
eral neurological disorders. Whether failures in synaptic
function and dendritic structure caused by decreased
insulin receptor signaling contribute to brain diseases
later in life is an important issue to address.
Synapse formation or maintenance?
Precise synaptic connectivity is required for normal
brain function, yet synaptic connectivity is dynamic as a
result of constant synapse formation and elimination.
Therefore, the reduced synapse number seen in dnIR-
expressing neurons could be due to a function of insulin
receptor signaling in synapse formation or synapse
maintenance. If insulin receptor signaling promotes
synapse formation, disrupting insulin receptor signaling
should cause a shift in average maturity of the synapse
population because dnIR expression would block new
synapse formation but not maturation of existing
synapses; however, postsynaptic AMPA/NMDA ratios or
presynaptic maturation indexes were not different in
dnIR-expressing neurons compared to controls. Further-
more, our ultrastructural observations indicate that the
synapses onto dnIR-expressing neurons have similar
maturation indices as controls. Finally, we find that the
fraction of silent synapses is not altered in dnIR-expres-
sing neurons compared to controls. These three pieces
of evidence suggest that insulin receptor signaling is not
required for synapse formation and is, therefore, more
likely to regulate synapse connectivity through synapse
maintenance. Collectively, these results indicate that
synapse maturation and the balance of synapse forma-
tion and elimination could be separately regulated in
vivo, and that insulin receptor signaling has an impact
specifically on the synapse numbers by regulating
synapse elimination. Moderate expression of PSD-95 has
been used as an in vivo synaptic marker without signifi-
cantly affecting synaptic density in Xenopus tadpoles
and other vertebrates [147,185]. Therefore, it would be
interesting to perform in vivo time-lapse imaging to
monitor synapse dynamics by tracking fluorescently
tagged PSD-95 puncta in optic tectal cell dendrites.
Detailed analysis of synapse behaviors - for example, to
determine numbers of added, stable and lost synapses in
dnIR- or GFP-transfected neurons - would provide a
direct test of the hypothesis and could elucidate the
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lating synapse connectivity.
Endogenous ligand and receptor composition
Insulin is thought to be the primary ligand for the insu-
lin receptor; however, IGF-2 also reportedly binds the
homodimer of the insulin receptor splice variant in the
brain [95]. Moreover, the discovery that the insulin
receptor and IGF-1 receptor heterodimerize expands the
potential ligands for insulin receptor heterodimers in
the brain to include insulin, IGF-2, IGF-1 and possibly
others [86]. Several potential ligands - for example,
mammalian insulin and nematode insulin and IGFs -
have been reported to affect synaptic transmission
and plasticity, dendrite structure, whole animal
lifespan and behaviors in various model systems
[101,105-107,186-189]. The identity of the primary
ligand(s) that activate insulin receptor signaling and reg-
ulate synapse number, where the ligands are found in
the brain and how are they regulated are all important
questions requiring further exploration.
At the receptor level, it is important to investigate the
composition of the receptor dimer since it determines
the specificity and affinity of the ligand(s) and might
initiate distinct downstream signaling pathways. Our
strategy of using dnIR expression can potentially disrupt
three types of receptor signaling according to the recep-
tor composition: the insulin receptor homodimer; the
insulin receptor-IGF-1 receptor heterodimer; and the
IGF-1 receptor homodimer. It is interesting to note that
when antisense morpholino oligonucleotides were used
to specifically knockdown insulin receptor but not
IGF-1 receptor, morpholino-transfected neurons show a
similar deficit in visual responses recorded in vivo com-
pared to dnIR-expressing neurons. This result indicates
that the insulin receptor, instead of the IGF-1 receptor,
plays major roles in visual circuit function. Nevertheless,
whether the insulin receptor executes its function
through the insulin receptor homodimer or the insulin
receptor/IGF-1 receptor heterodimer is still an open
question. Traditional co-immunoprecipitation of
the insulin receptor dimers from brain lysate might help
in deciphering the receptor composition if one can
develop specific antibodies to differentiate these two
structurally similar receptors. Alternatively, molecular
tools - for example, morpholino or RNA interference -
to specifically knockdown the insulin receptor, the
IGF-1 receptor alone, or both together may provide
further insight.
Molecular mechanisms
The decrease in insulin receptor signaling by dnIR
expression affects visual responses in tectal neurons to
the same extent as morpholino-mediated knockdown of
insulin receptor protein, indicating that kinase activity
of the insulin receptor plays a major role in insulin
receptor function. What are the downstream cascades
activated by insulin receptor kinase activity in the CNS?
Studies in peripheral tissues have demonstrated that
MAPK or Akt are major pathways downstream of the
insulin receptor [88]. Whether MAPK or Akt pathways
underlie insulin receptor-mediated circuit development
needs to be further explored. In addition to these gen-
eral pathways, some molecules appear to be more speci-
fic to insulin receptor signaling, for example, IRSs [190].
As mentioned before, IRSp53 is a great candidate to
execute insulin receptor function at excitatory synapses
by regulating the actin cytoskeleton through a pathway
that requires its coupling with activated Rho GTPase
[77,140,141]. Whether this effect on actin cytoskeleton
originates from insulin receptor signaling would be
interesting to know. Recently, the phosphorylation sites
of IRSp53 that specifically respond to insulin receptor
signaling have been discovered [191]. Mutations of
these sites would allow us to understand the interplay
between the insulin receptor, IRSp53 and RhoGTPases
in the structural aspects of circuit development.
Neurological disorders
Accumulating data suggest a potential link between
insulin receptor signaling and several neurological disor-
ders. As mentioned above, enhanced insulin receptor
signaling has been one strategy for clinical treatments
for patients with Alzheimer’s disease [150-152] and schi-
zophrenia [148,149], although the underlying mechan-
ism is not clear. One common pathological hallmark for
Alzheimer’s disease and schizophrenia is the problem in
circuit function as a result of reduced synaptic connec-
tivity [176-178,192]. The discovery of a crucial role for
the insulin receptor in synapse maintenance and circuit
function suggests a cellular mechanism to illustrate how
impaired insulin receptor signaling may contribute to
neurological disorders. Nevertheless, improved treat-
ments and additional research are needed to understand
the detailed molecular mechanism by which the insulin
receptor affects synapse loss or function of brain cir-
cuits. A transgenic model system in which insulin recep-
tor levels or signaling could be controlled with spatial
and temporal resolution would be beneficial in exploring
the detailed mechanisms at the molecular level and the
pathogenesis at the behavioral level. Since whole system
knockouts of insulin receptor in mice are lethal [193],
conditional knockouts will be required. In fact, neuron
specific insulin receptor knockout mice that are viable
have been developed and they show decreased phos-
phorylation of Akt and glycogen synthase kinase 3 beta.
Interestingly, glycogen synthase kinase 3 beta is again
highly associated with Alzheimer’s disease [155,194] and
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Page 13 of 18schizophrenia [195]. Further research on this type of
transgenic system will provide insight into the physiolo-
gical function of the insulin receptor in the development
of the normal brain as well as the etiology of neurologi-
cal diseases.
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